These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 30701326)

  • 1. NRF2 orchestrates the redox regulation induced by radiation therapy, sustaining embryonal and alveolar rhabdomyosarcoma cells radioresistance.
    Marampon F; Codenotti S; Megiorni F; Del Fattore A; Camero S; Gravina GL; Festuccia C; Musio D; De Felice F; Nardone V; Santoro AN; Dominici C; Fanzani A; Pirtoli L; Fioravanti A; Tombolini V; Cheleschi S; Tini P
    J Cancer Res Clin Oncol; 2019 Apr; 145(4):881-893. PubMed ID: 30701326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulating the dose-rate differently affects the responsiveness of human epithelial prostate- and mesenchymal rhabdomyosarcoma-cancer cell line to radiation.
    Petragnano F; Pietrantoni I; Di Nisio V; Fasciani I; Del Fattore A; Capalbo C; Cheleschi S; Tini P; Orelli S; Codenotti S; Mazzei MA; D'Ermo G; Pannitteri G; Tombolini M; De Cesaris P; Riccioli A; Filippini A; Milazzo L; Vulcano F; Fanzani A; Maggio R; Marampon F; Tombolini V
    Int J Radiat Biol; 2020 Jun; 96(6):823-835. PubMed ID: 32149569
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinically relevant radioresistant rhabdomyosarcoma cell lines: functional, molecular and immune-related characterization.
    Petragnano F; Pietrantoni I; Camero S; Codenotti S; Milazzo L; Vulcano F; Macioce G; Giordani I; Tini P; Cheleschi S; Gravina GL; Festuccia C; Rossetti A; Delle Monache S; Ordinelli A; Ciccarelli C; Mauro A; Barbara B; Antinozzi C; Schiavetti A; Maggio R; Di Luigi L; Polimeni A; Marchese C; Tombolini V; Fanzani A; Bernabò N; Megiorni F; Marampon F
    J Biomed Sci; 2020 Aug; 27(1):90. PubMed ID: 32854690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential response of DU145 and PC3 prostate cancer cells to ionizing radiation: role of reactive oxygen species, GSH and Nrf2 in radiosensitivity.
    Jayakumar S; Kunwar A; Sandur SK; Pandey BN; Chaubey RC
    Biochim Biophys Acta; 2014 Jan; 1840(1):485-94. PubMed ID: 24121106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and activity of vascular endothelial growth factor and metalloproteinases in alveolar and embryonal rhabdomyosarcoma cell lines.
    Onisto M; Slongo ML; Gregnanin L; Gastaldi T; Carli M; Rosolen A
    Int J Oncol; 2005 Sep; 27(3):791-8. PubMed ID: 16077930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gain of Nrf2 function in non-small-cell lung cancer cells confers radioresistance.
    Singh A; Bodas M; Wakabayashi N; Bunz F; Biswal S
    Antioxid Redox Signal; 2010 Dec; 13(11):1627-37. PubMed ID: 20446773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyper-activation of Notch3 amplifies the proliferative potential of rhabdomyosarcoma cells.
    De Salvo M; Raimondi L; Vella S; Adesso L; Ciarapica R; Verginelli F; Pannuti A; Citti A; Boldrini R; Milano GM; Cacchione A; Ferrari A; Collini P; Rosolen A; Bisogno G; Alaggio R; Inserra A; Locatelli M; Stifani S; Screpanti I; Miele L; Locatelli F; Rota R
    PLoS One; 2014; 9(5):e96238. PubMed ID: 24797362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of met as a therapeutic target in alveolar and embryonal rhabdomyosarcoma.
    Taulli R; Scuoppo C; Bersani F; Accornero P; Forni PE; Miretti S; Grinza A; Allegra P; Schmitt-Ney M; Crepaldi T; Ponzetto C
    Cancer Res; 2006 May; 66(9):4742-9. PubMed ID: 16651427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nrf2 is a potential therapeutic target in radioresistance in human cancer.
    Zhou S; Ye W; Shao Q; Zhang M; Liang J
    Crit Rev Oncol Hematol; 2013 Dec; 88(3):706-15. PubMed ID: 24126138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PARP inhibitors affect growth, survival and radiation susceptibility of human alveolar and embryonal rhabdomyosarcoma cell lines.
    Camero S; Ceccarelli S; De Felice F; Marampon F; Mannarino O; Camicia L; Vescarelli E; Pontecorvi P; Pizer B; Shukla R; Schiavetti A; Mollace MG; Pizzuti A; Tombolini V; Marchese C; Megiorni F; Dominici C
    J Cancer Res Clin Oncol; 2019 Jan; 145(1):137-152. PubMed ID: 30357520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidative stress associated metabolic adaptations regulate radioresistance in human lung cancer cells.
    Singh B; Patwardhan RS; Jayakumar S; Sharma D; Sandur SK
    J Photochem Photobiol B; 2020 Dec; 213():112080. PubMed ID: 33232882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNMT3A and DNMT3B Targeting as an Effective Radiosensitizing Strategy in Embryonal Rhabdomyosarcoma.
    Camero S; Vitali G; Pontecorvi P; Ceccarelli S; Anastasiadou E; Cicchetti F; Flex E; Pomella S; Cassandri M; Rota R; Marampon F; Marchese C; Schiavetti A; Megiorni F
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An effective strategy for increasing the radiosensitivity of Human lung Cancer cells by blocking Nrf2-dependent antioxidant responses.
    Lee S; Lim MJ; Kim MH; Yu CH; Yun YS; Ahn J; Song JY
    Free Radic Biol Med; 2012 Aug; 53(4):807-16. PubMed ID: 22684019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer-Specific Energy Metabolism in Rhabdomyosarcoma Cells Is Regulated by MicroRNA.
    Sugito N; Taniguchi K; Kuranaga Y; Ohishi M; Soga T; Ito Y; Miyachi M; Kikuchi K; Hosoi H; Akao Y
    Nucleic Acid Ther; 2017 Dec; 27(6):365-377. PubMed ID: 28981396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The organophosphate chlorpyrifos disturbs redox balance and triggers antioxidant defense mechanisms in JEG-3 cells.
    Chiapella G; Flores-MartĂ­n J; Ridano ME; Reyna L; Magnarelli de Potas G; Panzetta-Dutari GM; Genti-Raimondi S
    Placenta; 2013 Sep; 34(9):792-8. PubMed ID: 23850137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological targeting of the ephrin receptor kinase signalling by GLPG1790 in vitro and in vivo reverts oncophenotype, induces myogenic differentiation and radiosensitizes embryonal rhabdomyosarcoma cells.
    Megiorni F; Gravina GL; Camero S; Ceccarelli S; Del Fattore A; Desiderio V; Papaccio F; McDowell HP; Shukla R; Pizzuti A; Beirinckx F; Pujuguet P; Saniere L; der Aar EV; Maggio R; De Felice F; Marchese C; Dominici C; Tombolini V; Festuccia C; Marampon F
    J Hematol Oncol; 2017 Oct; 10(1):161. PubMed ID: 28985758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factor-I has different effects on myogenin induction and cell cycle progression in human alveolar and embryonal rhabdomyosarcoma cells.
    Tsuchiya K; Hosoi H; Misawa-Furihata A; Houghton PJ; Sugimoto T
    Int J Oncol; 2007 Jul; 31(1):41-7. PubMed ID: 17549403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiation therapy may increase metastatic potential in alveolar rhabdomyosarcoma.
    Woods GM; Bondra K; Chronowski C; Leasure J; Singh M; Hensley L; Cripe TP; Chakravarti A; Houghton P
    Pediatr Blood Cancer; 2015 Sep; 62(9):1550-1554. PubMed ID: 25790258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MS-275 (Entinostat) Promotes Radio-Sensitivity in PAX3-FOXO1 Rhabdomyosarcoma Cells.
    Cassandri M; Pomella S; Rossetti A; Petragnano F; Milazzo L; Vulcano F; Camero S; Codenotti S; Cicchetti F; Maggio R; Festuccia C; Gravina GL; Fanzani A; Megiorni F; Catanoso M; Marchese C; Tombolini V; Locatelli F; Rota R; Marampon F
    Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNMT3B in vitro knocking-down is able to reverse embryonal rhabdomyosarcoma cell phenotype through inhibition of proliferation and induction of myogenic differentiation.
    Megiorni F; Camero S; Ceccarelli S; McDowell HP; Mannarino O; Marampon F; Pizer B; Shukla R; Pizzuti A; Marchese C; Clerico A; Dominici C
    Oncotarget; 2016 Nov; 7(48):79342-79356. PubMed ID: 27764816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.